Areas of Abstract Submission
Submission of abstracts in the following areas is encouraged:
Basic Science of Clinical Pharmacology
- Clinical Pharmacokinetics (ADME)
- Drug Interactions
- Experimental Pharmacology in In Vitro/In Vivo Studies
- Human Pharmacology
- Mechanism of Action
- Pharmacogenomics
- Pharmacodynamics
- Therapeutic Drug Monitoring
- Translational Medicine (Biomarkers/Imaging)
- Transporters
Quantitative
- Applications of Modeling & Simulation
- Big Data Science & Analytics
- Digital Health
- Emerging Technologies
- Innovative Statistical Methods
- Pharmacometrics & Systems Pharmacology
- Precision Medicine
Drug Development
- Biosimilars
- Clinical Trials
- Decision Making in Research & Development
- Drug Development
- Model-informed Drug Development
- New & Adaptive Clinical Trial Designs
- Novel Use of Therapeutics/Drug Repurposing
- Regulatory Issues
Applied Clinical Pharmacology Techniques
- Adverse Drug Effects
- Drug Effectiveness
- Pharmacoeconomics
- Pharmacoepidemiology
- Quality of Life
- Real-world Evidence in Decision Making
- Risk Management/Legal Issues
- Safety & Efficacy
Therapeutic Areas of Applied Clinical Pharmacology
- Disease Management
- Drug Dependence
- HIV/AIDS
- Immunology/Immunotherapy
- Infectious Diseases
- Oncology/Immuno-oncology
- Other Therapeutic Areas
- Rare Diseases
- Pediatrics
- Special Populations
- Women’s Health
Unique
- Clinical Pharmacology Education
Primary criteria for acceptance of abstracts are:
- Applicability to clinical pharmacology and translational medicine;
- Innovation and scientific merit;
- Relevance to ACCP's mission.
Each abstract must contain:
- A statement of purpose, innovation or hypothesis;
- Description of methods and materials;
- Data and results;
- Interpretation, conclusion and significance.